4.2 Letter

Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia

Journal

EXPERIMENTAL HEMATOLOGY
Volume 34, Issue 5, Pages 571-572

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.exphem.2006.02.009

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available